Demant

Demant, a Surgical and Medical Instrument Manufacturing company headquartered in DK, reported total emissions of approximately 221,757 tonnes CO2e in 2025. This includes about 15,893 tonnes CO2e from Scope 1 emissions, 10,888 tonnes CO2e from Scope 2 market-based emissions, and 194,976 tonnes CO2e from Scope 3 emissions.

In 2024, their total emissions were approximately 238,708 tonnes CO2e, comprising around 14,645 tonnes CO2e from Scope 1, 14,781 tonnes CO2e from Scope 2 market-based emissions, and 209,282 tonnes CO2e from Scope 3 emissions. Looking further back, in 2019, Demant's total emissions were approximately 188,774 tonnes CO2e. This included roughly 11,206 tonnes CO2e from Scope 1, 20,774 tonnes CO2e from Scope 2 market-based emissions, and 156,794 tonnes CO2e from Scope 3 emissions.

Demant has established ambitious climate commitments, with targets approved by the Science Based Targets initiative (SBTi). The company commits to reaching net-zero greenhouse gas (GHG) emissions across its value chain by 2050 from a 2019 base year.

Their near-term targets include:

• Reducing absolute Scope 1 and 2 GHG emissions by 46.2% by 2030 from a 2019 base year.
• Reducing absolute Scope 3 GHG emissions by 46.2% by 2030 from a 2019 base year.

For long-term targets, Demant aims to:

• Reduce absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2019 base year.
• Reduce absolute Scope 3 GHG emissions by 90% by 2050 from a 2019 base year.

These targets are considered consistent with reductions required to keep global warming to 1.5°C. Demant is actively working on initiatives such as transitioning to electric vehicles to reduce Scope 1 emissions and aiming for 100% renewable electricity by 2030 for Scope 2 emissions. All emissions data and reduction targets are directly reported by Demant A/S.